相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mycobacterium avium complex immune reconstitution inflammatory syndrome:: Long term outcomes
James Riddell et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells
M. A. French et al.
HIV MEDICINE (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Mycobacterium avium-induced SOCS contributes to resistance to IFN-γ-mediated mycobactericidal activity in human macrophages
Nancy Vazquez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Biosynthesis of mycobacterial lipoarabinomannan: Role of a branching mannosyltransferase
Devinder Kaur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts:: A EuroSIDA study
Daria Podlekareva et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Sequencing of hsp65 distinguishes among subsets of the Mycobacterium avium complex
CY Turenne et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Direct identification of slowly growing Mycobacterium species by analysis of the intergenic 16S-23S rDNA spacer region (ISR) using a GelCompar II database containing sequence based optimization for restriction fragment site polymoiphisms (RFLPs) for 12 enzymes
V Gürtler et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2006)
Clinical, microbiological, and immunological characteristics in HIV-Infected subjects at risk for disseminated Mycobacterium avium complex disease:: An AACTG study
RR MacGregor et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals
SD Lawn et al.
LANCET INFECTIOUS DISEASES (2005)
CD4+ T cells but not CD8+ or γδ+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route
M Petrofsky et al.
INFECTION AND IMMUNITY (2005)
Survival of Mycobacterium avium in a model distribution system
CD Norton et al.
WATER RESEARCH (2004)
Interferon-gamma therapy activates human monocytes for enhanced phagocytosis of Mycobacterium avium complex in HIV-infected individuals
K Kedzierska et al.
HIV CLINICAL TRIALS (2004)
Immune restoration disease after antiretroviral therapy
MA French et al.
AIDS (2004)
Evaluation of bone marrow and blood cultures for the recovery of mycobacteria in the diagnosis of disseminated mycobacterial infections
E Pacios et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India
N Kumarasamy et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Comparative evaluation of the new version of the INNO-LiPA mycobacteria and GenoType mycobacterium assays for identification of Mycobacterium species from MB/BacT liquid cultures artificially inoculated with mycobacterial strains
E Padilla et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Disseminated Mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy - Is prophylaxis still indicated
CG Lange et al.
DRUGS (2004)
Adjuitctive immunotherapy of mycobacterial infections
H Tomioka
CURRENT PHARMACEUTICAL DESIGN (2004)
Effects of macrolides and ketolides on mycobacterial infections
LE Bermudez et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Health impacts of environmental mycobacteria
TP Primm et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
CA Benson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Viable Mycobacterium avium is required for the majority of human immunodeficiency virus-induced upregulation in monocytoid cells
M Ghassemi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Characterization of biofilm formation by clinical isolates of Mycobacterium avium
G Carter et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
The complexity of HLA class II (DRB1, DQB1, DM) associations with disseminated Mycobacterium avium complex infection among HIV-1-seropositive whites
E Naik et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s
E Tortoli
CLINICAL MICROBIOLOGY REVIEWS (2003)
Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory
L Hall et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Mycobacterium avium invades the intestinal mucosa primarily by interacting with enterocytes
FJ Sangari et al.
INFECTION AND IMMUNITY (2001)
Interferon-γ and interleukin-12 pathway defects and human disease
SE Dorman et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2000)
Drug-drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease
JJ Kuper et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
